Федотова Е. В., Петрушин А. Л., Нечаева М. Н., Шаньгин О. А., Вальков М. Ю. Нейроэндокринные опухоли тонкой кишки: клинический случай и обзор литературы. Медицинский вестник Башкортостана. 2025;20(1):111-120.
1. Клинические рекомендации. Нейроэндокринные опухоли. – Москва, 2020. – 54 с.
2. Ahmed, M. Gastrointestinal neuroendocrine tumors in 2020 / M. Ahmed // World J. Gastrointest. Oncol. – 2020. – Vol. 12. – № 8. – P. 791-807.
3. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases / A. P. Burke, R. M. Thomas, A. M. Elsayed, L. H. Sobin // Cancer. – 1997. – Vol. 79. – P. 1086-1093.
4. Characterization of the Neuroendocrine Tumor Immune Microenvironment / A. da Silva [et al.] // Pancreas. – 2018. – Vol. 47. – P. 1123-1129.
5. Cives, M. Gastroenteropancreatic Neuroendocrine Tumors / M. Cives, J. R. Strosberg // CA Cancer. J. Clin. – 2018. – Vol. 68. – P. 471-487.
6. Clinical signs of fibrosis in small intestinal neuroendocrine tumours / K. Daskalakis [et al.] // Br. J. Surg. – 2017. – Vol. 104. – P. 69-75.
7. CTGF, intestinal stellate cells and carcinoid fibrogenesis / M. Kidd [et al.] // World J. Gastroenterol. – 2007. – Vol. 13. – P. 5208-5216.
8. Current management of gastrointestinal carcinoid tumors / K. J. Woodside, C.M. Townsend, B. Mark Evers // J. Gastrointest. Surg. – 2004. – № 8. – P. 742-756.
9. Current status of gastrointestinal carcinoids / I.M. Modlin [et al.] // Gastroenterology. – 2005. – Vol. 128. – P. 1717-1751.
10. European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease / S. Grozinsky-Glasberg [et al.] // J. Neuroendocrinol. – 2022. – Vol. 34, № 7. – P. e13146.
11. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma / H. Sorbye [et al.] // J. Neuroendocrinol. – 2023.–Vol. 35, № 3. – P. e13249.
12. Examining rectal carcinoids in the era of screening colonoscopy: a surveillance, epidemiology, and end results analysis / S. Taghavi [et al.] // Dis. Colon. Rectum. – 2013. – Vol. 56. – P. 952-959.
13. Fox, D.J. Carcinoid heart disease: presentation, diagnosis, and management / D.J. Fox, R.S. Khattar // Heart. – 2004. – Vol. 90. – P. 1224-1228.
14. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior / G. Rindi [et al.] // World. J. Surg. – 1996. – № 20. – P. 168-172.
15. Incidence and survival of neuroendocrine neoplasia in England 1995–2018: a retrospective, population-based study / B. E. White [et al.] // Lancet. – 2022. – Vol. 23. – P. 100510.
16. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature / M. Fraenkel [et al.] // Endocr. Relat. Cancer. – 2014. – Vol. 21, № 3. – P. 153-163.
17. Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel / M. R. Druce [et al.] // QJM. – 2010. – Vol. 103. P. 177-185.
18. Kim, J. Y. Recent updates on grading and classification of neuroendocrine tumors / J. Y. Kim, S. M. Hong, J. Y. Ro // Ann. Diagn. Pathol. – 2017. – Vol. 29. P. 11-16.
19. Klöppel, G. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification / G. Klöppel, A. Perren, P. U. Heitz // Ann. N Y Acad Sci. – 2004. – Vol. 1014. – P. 13-27.
20. Maggard, M. A. Updated population-based review of carcinoid tumors / M. A. Maggard, J. B. O'Connell, C. Y. Ko // Ann. Surg. – 2004. – Vol. 240. – P. 117-122.
21. Moertel, C. G. Karnofsky memorial lecture. An odyssey in the land of small tumors / C. G. Moertel // J. Clin. Oncol. – 1987. – № 5. – P. 1502-22.
22. Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets / J. Capdevila [et al.] // Cancer. Metastasis. Rev. – 2014. – Vol. 33. – P. 345-351.
23. Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review / E.E. Ilett [et al.] // Diagnostics (Basel). – 2015. – № 5. – P. 119-176.
24. Neuroendocrine tumors of the small intestine causing a desmoplastic reaction of the mesentery are a more aggressive cohort / F. Bösch [et al.] // Surgery. – 2018. – Vol. 164. – P. 1093-1099.
25. Pasieka, J. L. Carcinoid tumors. / J. L. Pasieka // Surg. Clin. North. Am. – 2009. Vol. 89. – P. 1123-1137.
26. Primary small-cell neuroendocrine carcinoma of the duodenum – a case report and review of literature / N. Sata [et al.] // World J. Surg. Oncol. – 2004. – № 2. – P. 28.
27. Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum / A. Blažević [et al.] // Endocr. Relat. Cancer. – 2018. – Vol. 25. – P. 115-130.
28. The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors / R. A. Ramirez [et al.] // Oncologist. – 2016. – Vol. 21. – P. 671-675.
29. The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications / M. Cives [et al.] // Neuroendocrinology. – 2019. – Vol. 109. P. 83-99.
30. Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors / S. Krug [et al.] // Int. J. Cancer. – 2018. – Vol. 143. – P. 1806–
31. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States / A. Dasari [et al.] // JAMA Oncol. – 2017. – Vol. 3, № 10. – P. 1335-1342.
32. Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease / S. Bhattacharyya, C. Toumpanakis, M.E. Caplin, J. Davar // Am. J. Cardiol. – 2008. – Vol. 102. – P. 938-942.
